Literature DB >> 23530978

Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.

Narendra Battula1, Dimitrios Tsapralis, David Mayer, John Isaac, Paolo Muiesan, Robert P Sutcliffe, Simon Bramhall, Darius Mirza, Ravi Marudanayagam.   

Abstract

OBJECTIVES: Isolated intrahepatic recurrence is noted in up to 40% of patients following curative liver resection for colorectal liver metastases (CLM). The aims of this study were to analyse the outcomes of repeat hepatectomy for recurrent CLM and to identify factors predicting survival.
METHODS: Data for all liver resections for CLM carried out at one centre between 1998 and 2011 were analysed.
RESULTS: A total of 1027 liver resections were performed for CLM. Of these, 58 were repeat liver resections performed in 53 patients. Median time intervals were 10.5 months between the primary resection and first hepatectomy, and 15.4 months between the first and repeat hepatectomies. The median tumour size was 3.0 cm and the median number of tumours was one. Six patients had a positive margin (R1) resection following first hepatectomy. There were no perioperative deaths. Significant complications included transient liver dysfunction in one and bile leak in two patients. Rates of 1-, 3- and 5-year overall survival following repeat liver resection were 85%, 61% and 52%, respectively, at a median follow-up of 23 months. R1 resection at first hepatectomy (P = 0.002), a shorter time interval between the first and second hepatectomies (P = 0.02) and the presence of extrahepatic disease (P = 0.02) were associated with significantly worse overall survival.
CONCLUSIONS: Repeat resection of CLM is safe and can achieve longterm survival in carefully selected patients. A preoperative knowledge of poor prognostic factors helps to facilitate better patient selection.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23530978      PMCID: PMC3921011          DOI: 10.1111/hpb.12096

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  45 in total

1.  Postoperative complications of repeat hepatectomy for liver metastasis from colorectal carcinoma.

Authors:  M Aramaki; K Kawano; T Kai; A Sasaki; T Ohno; K Tahara; Y Takeuchi; T Yoshida; S Kitano
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

Review 2.  Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis.

Authors:  Henrik Petrowsky; Mithat Gonen; William Jarnagin; Matthias Lorenz; Ronald DeMatteo; Stefan Heinrich; Albrecht Encke; Leslie Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.

Authors:  L Solbiati; T Livraghi; S N Goldberg; T Ierace; F Meloni; M Dellanoce; L Cova; E F Halpern; G S Gazelle
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

4.  Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.

Authors:  D Elias; T De Baere; T Smayra; J F Ouellet; A Roche; P Lasser
Journal:  Br J Surg       Date:  2002-06       Impact factor: 6.939

5.  Impact of repeat hepatectomy on recurrent colorectal liver metastases.

Authors:  S Suzuki; T Sakaguchi; Y Yokoi; K Kurachi; K Okamoto; T Okumura; Y Tsuchiya; T Nakamura; H Konno; S Baba; S Nakamura
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

Review 6.  A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma.

Authors:  Annelore Altendorf-Hofmann; Johannes Scheele
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

7.  Liver resection for colorectal metastases: the third hepatectomy.

Authors:  René Adam; Gérard Pascal; Daniel Azoulay; Kuniya Tanaka; Denis Castaing; Henri Bismuth
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

8.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

9.  Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment.

Authors:  Kun-Ming Chan; Jy-Ming Chiang; Chen-Fang Lee; Ming-Chin Yu; Wei-Chen Lee; Jinn-Shiun Chen; Jeng-Yi Wang
Journal:  World J Surg Oncol       Date:  2011-12-30       Impact factor: 2.754

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  17 in total

1.  Neoadjuvant transarterial radiation lobectomy for colorectal hepatic metastases: a small cohort analysis on safety, efficacy, and radiopathologic correlation.

Authors:  Jehan L Shah; Ivan R Zendejas-Ruiz; Linday M Thornton; Brian S Geller; Joseph R Grajo; Amy Collinsworth; Thomas J George; Beau Toskich
Journal:  J Gastrointest Oncol       Date:  2017-06

2.  Fouling-resistant zwitterionic polymers for complete prevention of postoperative adhesion.

Authors:  Ershuai Zhang; Boyi Song; Yuanjie Shi; Hui Zhu; Xiangfei Han; Hong Du; Chengbiao Yang; Zhiqiang Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-30       Impact factor: 11.205

3.  Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.

Authors:  Jocelyn Bellier; Julien De Wolf; Mohamed Hebbar; Mehdi El Amrani; Christophe Desauw; Emmanuelle Leteurtre; François-René Pruvot; Henri Porte; Stéphanie Truant
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

4.  Surgical salvage of recurrence after resection of colorectal liver metastases: incidence and outcomes.

Authors:  Nuh N Rahbari; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2017-08-03

5.  Repeat hepatic resection in patients with colorectal liver metastases.

Authors:  Huisong Lee; Seong Ho Choi; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Woo Yong Lee; Jin Seok Heo; Dong Wook Choi; Kyung Uk Jung; Ho-Kyung Chun
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 6.  Postoperative complications affect long-term survival outcomes following hepatic resection for colorectal liver metastasis.

Authors:  Zi Yin; Xiande Huang; Tingting Ma; Haosheng Jin; Ye Lin; Min Yu; Zhixiang Jian
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

7.  RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.

Authors:  Jason W Denbo; Suguru Yamashita; Guillaume Passot; Michael Egger; Yun S Chun; Scott E Kopetz; Dipen Maru; Kristoffer Watten Brudvik; Steven H Wei; Claudius Conrad; Jean-Nicolas Vauthey; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2016-06-22       Impact factor: 3.452

8.  Postoperative complications following aggressive repeat hepatectomy for colorectal liver metastasis have adverse oncological outcomes.

Authors:  Yasuyuki Fukami; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Shunsuke Onoe
Journal:  Surg Today       Date:  2016-04-27       Impact factor: 2.549

9.  Repeat hepatectomy for recurred colorectal liver metastasis: is it justified?

Authors:  Jangho Park; Seung-Duk Lee; Sung-Sik Han; Seoung Hoon Kim; Sang-Jae Park; Jae Hwan Oh; Jungnam Joo
Journal:  Ann Surg Treat Res       Date:  2019-06-26       Impact factor: 1.859

10.  Outcomes of laparoscopic repeat liver resection for recurrent liver cancer: A system review and meta-analysis.

Authors:  Yufu Peng; Fei Liu; Yonggang Wei; Bo Li
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.